Back
Protagonist Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
PTGX
Protagonist Therapeutics
Last Price:
44.50
Seasonality Move:
11.46%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...Protagonist Therapeutics Price Quote
$44.50
+2.85 (+6.84%)
(Updated: November 22, 2024 at 12:40 PM ET)
Protagonist Therapeutics Key Stats
Sell
33
Protagonist Therapeutics (PTGX)
is a Sell
Day range:
$40.72 - $43.38
52-week range:
$16.80 - $48.89
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.95
P/B ratio:
4.67%
Volume:
936.4K
Avg. volume:
655.9K
1-year change:
139.92%
Market cap:
$2.5B
Revenue:
$60M
EPS:
$2.66
How Much Does Protagonist Therapeutics Make?
-
How Much Are Protagonist Therapeutics's Sales Annually?
PTGX Revenues are $60M -
How Much Profit Does Protagonist Therapeutics's Make A Year?
PTGX net income is -$79M
Is Protagonist Therapeutics Growing As A Company?
Data Unavailable
Protagonist Therapeutics Stock Price Performance
-
Did Protagonist Therapeutics Stock Go Up Last Month?
Protagonist Therapeutics share price went down by -9.38% last month -
Did PTGX's Share Price Rise Over The Last Year?
PTGX share price rose by 139.92% over the past 1 year
What Is Protagonist Therapeutics 52-Week High & Low?
-
What Is Protagonist Therapeutics’s 52-Week High Share Price?
Protagonist Therapeutics has traded as high as $48.89 over the past 52 weeks -
What Is Protagonist Therapeutics’s 52-Week Low Share Price?
Protagonist Therapeutics has traded as low as $16.80 over the past 52 weeks
Protagonist Therapeutics Price To Free Cash Flow
-
Is Protagonist Therapeutics Stock Overvalued?
Protagonist Therapeutics is trading at a price to free cash flow ratio of 11.22 -
Is Protagonist Therapeutics Stock Undervalued?
Protagonist Therapeutics EV to Free Cash Flow ratio is 8.78 -
What Is Protagonist Therapeutics’s Price Earnings Growth Ratio?
PTGX PEG ratio is 0.00 -
Is Protagonist Therapeutics Trading At A Premium To Earnings?
Protagonist Therapeutics EV to EBIT ratio is 13.50
Is It Risky To Buy Protagonist Therapeutics?
-
How Much Debt Does Protagonist Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Protagonist Therapeutics Have?
Cash and short term investments quarterly total is $468.7M -
What Is Protagonist Therapeutics’s Book Value Per Share?
Book value per share is 8.94
Is Protagonist Therapeutics Cash Flow Positive?
-
What Is PTGX Cash Flow From Operations?
Cash flow from operations (TTM) is $230.3M -
What Is Protagonist Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $22.3M -
What Is Protagonist Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$352M
Protagonist Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
PTGX return on invested capital is 37.59% -
What Is Protagonist Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is 33.69% -
What Is PTGX Return On Equity?
ROE is a measure of profitability and is 37.59%
Protagonist Therapeutics Earnings Date & Stock Price
-
What Is Protagonist Therapeutics's Stock Price Today?
A single share of PTGX can be purchased today for 41.65 -
What Is Protagonist Therapeutics’s Stock Symbol?
Protagonist Therapeutics trades on the nasdaq under the ticker symbol: PTGX -
When Is Protagonist Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Protagonist Therapeutics is scheduled on February 27, 2025 -
When Is PTGX's next ex-dividend date?
Protagonist Therapeutics's next ex-dividend date is November 22, 2024 -
How To Buy Protagonist Therapeutics Stock?
You can buy Protagonist Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Protagonist Therapeutics Competitors
-
Who Are Protagonist Therapeutics's Competitors?
Below is a list of companies who compete with Protagonist Therapeutics or are related in some way:
Protagonist Therapeutics Dividend Yield
-
What Is PTGX Dividend Yield?
Protagonist Therapeutics’s dividend yield currently is 0% -
What Is Protagonist Therapeutics’s Payout Ratio?
Protagonist Therapeutics’s payout ratio is 0% -
When Did Protagonist Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 22, 2024 -
What Is Protagonist Therapeutics’s Dividend Per Share?
Protagonist Therapeutics pays a dividend of $0.00 per share
Protagonist Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -1.89% |
| Revenue: | 0% | 157.93% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 54.38 |
| Upside from Last Price: | 30.55% |